BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36301615)

  • 1. An App-Based Digit Symbol Substitution Test for Assessment of Cognitive Deficits in Adults With Major Depressive Disorder: Evaluation Study.
    McIntyre RS; Lipsitz O; Rodrigues NB; Subramaniapillai M; Nasri F; Lee Y; Fehnert B; King J; Chrones L; Kratiuk K; Uddin S; Rosenblat JD; Mansur RB; McCue M
    JMIR Ment Health; 2022 Oct; 9(10):e33871. PubMed ID: 36301615
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The THINC-it Tool for Cognitive Assessment and Measurement in Major Depressive Disorder: Sensitivity to Change.
    McIntyre RS; Subramaniapillai M; Park C; Zuckerman H; Cao B; Lee Y; Iacobucci M; Nasri F; Fus D; Bowie CR; Tran T; Rosenblat JD; Mansur RB
    Front Psychiatry; 2020; 11():546. PubMed ID: 32670103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Montreal Cognitive Assessment (MoCA) and Digit Symbol Substitution Test (DSST) as a screening tool for evaluation of cognitive deficits in schizophrenia.
    Daderwal MC; Sreeraj VS; Suhas S; Rao NP; Venkatasubramanian G
    Psychiatry Res; 2022 Oct; 316():114731. PubMed ID: 35926360
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluating the Utility of Smartphone-Based Sensor Assessments in Persons With Multiple Sclerosis in the Real-World Using an App (elevateMS): Observational, Prospective Pilot Digital Health Study.
    Pratap A; Grant D; Vegesna A; Tummalacherla M; Cohan S; Deshpande C; Mangravite L; Omberg L
    JMIR Mhealth Uhealth; 2020 Oct; 8(10):e22108. PubMed ID: 33107827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Network Meta-Analysis Comparing Effects of Various Antidepressant Classes on the Digit Symbol Substitution Test (DSST) as a Measure of Cognitive Dysfunction in Patients with Major Depressive Disorder.
    Baune BT; Brignone M; Larsen KG
    Int J Neuropsychopharmacol; 2018 Feb; 21(2):97-107. PubMed ID: 29053849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive symptoms in major depressive disorder: associations with clinical and functional outcomes in a 6-month, non-interventional, prospective study in China.
    Wang G; Si TM; Li L; Fang Y; Wang CX; Wang LN; Tan KHX; Ettrup A; Eriksen HF; Luo S; Ge L
    Neuropsychiatr Dis Treat; 2019; 15():1723-1736. PubMed ID: 31308667
    [No Abstract]   [Full Text] [Related]  

  • 7. Validation of a brain-computer interface version of the digit symbol substitution test in healthy subjects.
    Chen X; Hu N; Wang Y; Gao X
    Comput Biol Med; 2020 May; 120():103729. PubMed ID: 32250858
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reliability and validity of Chinese version of perceived deficits questionnaire for depression in patients with MDD.
    Shi C; Wang G; Tian F; Han X; Sha S; Xing X; Yu X
    Psychiatry Res; 2017 Jun; 252():319-324. PubMed ID: 28314227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of residual cognitive disturbances by early response of depressive symptoms to antidepressant treatments in patients with major depressive disorder.
    Sumiyoshi T; Hoshino T; Mishiro I; Hammer-Helmich L; Ge H; Moriguchi Y; Fujikawa K; Fernandez JL
    J Affect Disord; 2022 Jan; 296():95-102. PubMed ID: 34597893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of psychotropic drugs on digit substitution: comparison of the computerized symbol-digit substitution and traditional digit-symbol substitution tests.
    Mattila MJ; Aranko K; Mattila ME; Paakkari I
    J Psychopharmacol; 1994 Jan; 8(2):81-7. PubMed ID: 22298533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Validation of a digit symbol substitution test for use in supervised and unsupervised assessment in mild Alzheimer's disease.
    Williamson M; Maruff P; Schembri A; Cummins H; Bird L; Rosenich E; Lim YY
    J Clin Exp Neuropsychol; 2022 Dec; 44(10):768-779. PubMed ID: 36888758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PSYCHOMETRIC properties of the Chinese version of the THINC-it tool for cognitive symptoms in patients with major depressive disorder.
    Hou Y; Yao S; Hu S; Zhou Q; Han H; Yu X; McIntyre RS; Shi C
    J Affect Disord; 2020 Aug; 273():586-591. PubMed ID: 32560957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The THINC-Integrated Tool (THINC-it) Screening Assessment for Cognitive Dysfunction: Validation in Patients With Major Depressive Disorder.
    McIntyre RS; Best MW; Bowie CR; Carmona NE; Cha DS; Lee Y; Subramaniapillai M; Mansur RB; Barry H; Baune BT; Culpepper L; Fossati P; Greer TL; Harmer C; Klag E; Lam RW; Wittchen HU; Harrison J
    J Clin Psychiatry; 2017 Jul; 78(7):873-881. PubMed ID: 28858441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using a smartphone app to reduce cognitive vulnerability and mild depressive symptoms: Study protocol of an exploratory randomized controlled trial.
    Giosan C; Mogoaşe C; Cobeanu O; Szentágotai Tătar A; Mureşan V; Boian R
    Trials; 2016 Dec; 17(1):609. PubMed ID: 28031038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Effects of Vortioxetine on Cognitive Function in Patients with Major Depressive Disorder: A Meta-Analysis of Three Randomized Controlled Trials.
    McIntyre RS; Harrison J; Loft H; Jacobson W; Olsen CK
    Int J Neuropsychopharmacol; 2016 Jun; 19(10):. PubMed ID: 27312740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digit Symbol Substitution Test: The Case for Sensitivity Over Specificity in Neuropsychological Testing.
    Jaeger J
    J Clin Psychopharmacol; 2018 Oct; 38(5):513-519. PubMed ID: 30124583
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation and Functional Relevance of the Short Form of the Perceived Deficits Questionnaire for Depression for Japanese Patients with Major Depressive Disorder.
    Sumiyoshi T; Uchida H; Watanabe K; Oosawa M; Ren H; Moriguchi Y; Fujikawa K; Fernandez J
    Neuropsychiatr Dis Treat; 2022; 18():2507-2517. PubMed ID: 36353465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of a Web App for Cognitive Training (MeMo) Regarding Cognitive and Behavioral Performance in People With Neurocognitive Disorders: Randomized Controlled Trial.
    Robert P; Manera V; Derreumaux A; Ferrandez Y Montesino M; Leone E; Fabre R; Bourgeois J
    J Med Internet Res; 2020 Mar; 22(3):e17167. PubMed ID: 32159519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pain and major depressive disorder: Associations with cognitive impairment as measured by the THINC-integrated tool (THINC-it).
    Cha DS; Carmona NE; Mansur RB; Lee Y; Park HJ; Rodrigues NB; Subramaniapillai M; Rosenblat JD; Pan Z; Lee JH; Lee J; Almatham F; Alageel A; Shekotikhina M; Zhou AJ; Rong C; Harrison J; McIntyre RS
    Scand J Pain; 2017 Apr; 15():62-67. PubMed ID: 28850348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Symbol Digit Modalities Test Variant in a Smartphone App for Persons With Multiple Sclerosis: Validation Study.
    van Oirschot P; Heerings M; Wendrich K; den Teuling B; Martens MB; Jongen PJ
    JMIR Mhealth Uhealth; 2020 Oct; 8(10):e18160. PubMed ID: 33016886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.